![Steve Westing](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Steve Westing has been Vice President of Medical and Scientific Development for OccuLogix, Inc. since April 10, 2006.
Previously, he was Associate Director-Advisory and Thought Leader Services and a Member of the Ophthalmology Commercial Strategy Team for Genentech, Inc. Prior to joining Genentech in May 1996, Dr. Westing worked at Loredan Biomedical, Inc. since May 1990.
He received a PhD in Muscle Physiology from The Karolinska Institute, Stockholm, Sweden.
Anciens postes connus de Steve Westing
| Sociétés | Poste | Fin |
|---|---|---|
| TEARLAB CORPORATION | Directeur Technique/Scientifique/R&D | 09/01/2008 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Formation de Steve Westing
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
TearLab Corp., Inc.
 TearLab Corp., Inc. Medical SpecialtiesHealth Technology Develops point-of-care portable devices for measuring osmolarity to treat eye disorders | Health Technology |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
